title: Tumour-associated macrophages and cancer.
abstract: Our understanding of the complex roles and functions of tumour-associated myeloid cells has improved vastly over the last few years. Alternatively activated macrophages, TAMs, are an abundant part of solid and haematological malignancies and have been linked with progression, metastasis and resistance to therapy. Still, characterisation and TAM targeting is hindered by a lack of TAM specific markers, but advances in next generation technologies are rapidly increasing our understanding of the sheer diversity of myeloid differentiation and phenotypic regulation. These technologies help to shed light on the heterogeneous phenotypic states of myeloid cells within the tumour. Alternative approaches to influence the myeloid compartment within cancers surround inhibition of myeloid recruitment or 're-education' of the plastic TAM phenotype. Our knowledge continuously grows on how even 'established' therapies might influence the myeloid compartment within tumours. Now the promising results from elegant pre-clinical studies at first translate into the clinic and use combination therapies with myeloid inhibitors and standard chemotherapy.
authors.affiliation: Centre for Cancer and Inflammation, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London EC1M6BQ, UK.
authors.forename: Jenny
authors.initials: J
authors.lastname: Cook
authors.forename: Thorsten
authors.initials: T
authors.lastname: Hagemann
mesh_terms: D000818:Animals; D006801:Humans; D007249:Inflammation / Q000382:microbiology; D008264:Macrophages / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology*; D010641:Phenotype